Hilma J van der Horst

3PUBLICATIONS
8CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 06, 2025
Cytoskeletal dynamics and mitochondrial rearrangements drive cell fate upon antibody-induced complement activation in DLBCL.

Hilma J van der Horst, Tamás Csikós, Marjolein Quik

|Feb 19, 2021
Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment.

Hilma J van der Horst, A Vera de Jonge, Ida H Hiemstra

|Oct 22, 2020
Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies.

Hilma J van der Horst, Inger S Nijhof, Tuna Mutis

Pageof 1

Frequent Collaborators

2 joint publications

Esther C W Breij

2 joint publications

Tuna Mutis

1 joint publications

A Vera de Jonge

1 joint publications

Daphne de Jong